Patent · US Active

Combination of checkpoint kinase 1 inhibitors and wee 1 kinase inhibitors

US10434094B2 · kind B2 · utility

0Cited by
10References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 31, 2016
Grant dateOct 8, 2019
Priority date—
Expiry dateJan 18, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A combination of a CHK1 inhibitor and a WEE1 inhibitor are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.